Dr. Shouriyo Ghosh: Consultant at Clinical Haematology, Tata Medical Center Kolkata, India
Title/Designation: Dr.
Name: Shouriyo Ghosh
Current Role/Designation: Consultant
Organization/Institution: Clinical Haematology, Tata Medical Center, Kolkata
Country: India
Subject Track: Medicine
Key Areas of Expertise: Haematology and Stem Cell Transplants
Award Category: Best Innovator Award
Dr. Shouriyo Ghosh is a highly accomplished Consultant in Clinical Haematology and Cellular Therapies at Tata Medical Center, Kolkata, India, with broad experience in malignant and non-malignant haematological disorders. His clinical practice encompasses the management of leukemia, lymphoma, myeloma, aplastic anemia, and various bone marrow failure syndromes. He has extensive hands-on expertise in autologous and allogeneic stem cell transplantation, as well as in CAR-T cell therapy for relapsed and refractory B-cell malignancies. Dr. Ghosh’s work integrates cutting-edge laboratory insights with compassionate, evidence-based patient care. Alongside his clinical duties, he is deeply engaged in academic research, teaching, and multicenter collaborations aimed at advancing therapeutic strategies and improving survival outcomes for patients with complex hematologic diseases.
Online Profiles
Dr. Shouriyo Ghosh’s research impact is reflected through a strong and steadily growing citation record. As per current bibliometric data, his published works have accumulated 155 citations in total, with 127 citations since 2020, indicating significant recent influence in the field of clinical and translational haematology. His h-index of 6 and i10-index of 5 reflect both the productivity and sustained relevance of his scientific contributions across peer-reviewed journals. These metrics highlight his active role in advancing knowledge in hematologic malignancies, stem cell transplantation, and immunotherapy within both national and international research communities.
Education
Dr. Ghosh completed his M.B.B.S. from the University College of Medical Sciences (UCMS), University of Delhi in 2010, where he consistently ranked among the top students and received multiple awards for academic excellence. He pursued his M.D. in Pathology at the All India Institute of Medical Sciences (AIIMS), New Delhi, graduating in 2016, and later achieved his D.M. in Clinical Haematology from the Institute of Haematology and Transfusion Medicine, Medical College and Hospital, Kolkata in 2021. His strong academic trajectory reflects a blend of basic science foundation and clinical acumen, supported by an early inclination toward hematopathology, molecular diagnostics, and translational medicine.
Research Focus
Dr. Ghosh’s research lies at the intersection of clinical hematology, molecular pathology, and cellular therapies. His primary interests include outcome studies in acute leukemias, myelodysplastic syndromes (MDS), and chronic myeloid leukemia (CML), along with the optimization of transplant protocols and management of immunotherapy-related toxicities. He is actively involved in clinical trials and registry-based research, studying the efficacy and safety of novel agents like venetoclax, azacitidine, and HT-6184 in hematologic malignancies. Additionally, his work extends to exploring antimicrobial resistance patterns in transplant settings, the genetic characterization of thalassemia and hemoglobinopathies, and the real-world application of next-generation therapies such as CAR-T cells in Indian patient populations.
Experience
Dr. Ghosh’s professional journey reflects a steady progression through some of the most respected medical institutions in India and abroad. Since September 2023, he has been serving as a Consultant in Clinical Haematology and Cellular Therapies at Tata Medical Center, Kolkata. Previously, he completed a Leukemia and Bone Marrow Transplant Fellowship at Vancouver General Hospital, Canada (2022–2023), where he trained in advanced transplant methodologies and immunotherapeutic approaches. His earlier roles at Tata Medical Center included Clinical Associate and Senior Fellow, focusing on the management of transplant and immunotherapy patients. His training also encompasses a DM in Clinical Haematology (Medical College, Kolkata), MD Pathology (AIIMS, New Delhi), and extensive early experience as a Senior Resident in Haematology at NRSMCH, Kolkata. Collectively, these experiences have given him a deep clinical insight into hematological diseases, multidisciplinary care, and academic medicine.
Research Timeline & Activities
Dr. Ghosh’s research journey spans over a decade, beginning with molecular pathology and evolving toward translational clinical hematology. He currently serves as the Principal Investigator for the HCC registry study in Chronic Myeloid Leukemia (CML) initiated in 2024, and Co-Investigator for the MDS HT-6184-001 trial and PRIME trial on myeloid malignancies. He has contributed to numerous multicenter studies and presented his work at major international forums including SOHO (Houston, 2024), APBMT (Singapore, 2024), and Haematocon (New Delhi, 2019). His research timeline demonstrates a consistent focus on data-driven outcomes, quality improvement in transplant programs, and collaborative trials designed to enhance patient safety and treatment efficacy in hematologic cancers.
Awards & Honors
Dr. Ghosh’s excellence has been recognized with several prestigious honors. He received the Gold Medal for Best Outgoing Resident in Clinical Haematology (2020–2021) from the Medical College and Hospital, Kolkata, and the Dr. V. Ramalingaswami Medal (2016) from AIIMS, New Delhi, for his outstanding performance in pathology. During his academic career, he won multiple best oral and poster presentation awards at national conferences including APCON and Haematocon, along with numerous university distinctions in physiology, pathology, and forensic medicine. His awards highlight a consistent trajectory of academic distinction, clinical skill, and scientific innovation from undergraduate training through postdoctoral specialization.
Top Noted Publication
Among his wide-ranging publications in indexed international journals, Dr. Ghosh’s notable works include “Analysis of bloodstream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia” published in Annals of Hematology (2020), a study that remains influential in guiding infection control in hematology units. Another key contribution is “Thalidomide and Hydroxyurea in Transfusion-Dependent Thalassemia: Efficacy, Safety Profile and Impact on Quality of Life” (Hemoglobin, 2024), which offers important real-world insights into treatment optimization in thalassemia. His publications collectively cover themes of stem cell transplantation, hematologic malignancies, molecular genetics, and supportive care, reflecting his comprehensive engagement with both clinical and laboratory research in modern hematology.
-
Paul SB, Das P, Mahanta M, Sreenivas V, Kedia S, Kalra N, Kaur H, Vijayvargiya M, Ghosh S, et al.
Assessment of liver fibrosis in chronic hepatitis: comparison of shear wave elastography and transient elastography.
Abdominal Radiology, 42(12), 2864–2873, 2017.
Citations: 40
Significance: Demonstrated comparative diagnostic accuracy of shear wave and transient elastography in assessing hepatic fibrosis, widely referenced in hepatology and imaging research. -
Ghosh S, Chakraborty M, Samanta S, Sinha N, Saha S, Chattopadhyay A, Bhattacharyya M.
Analysis of bloodstream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia: data from a tertiary care haematology institute in India.
Annals of Hematology, 100(2), 395–403, 2021.
Citations: 27
Significance: Provided real-world insights into infection epidemiology and resistance trends in hematology patients, shaping antibiotic stewardship policies. -
Kumar K, Dhull VS, Karunanithi S, Chakraborty PS, Roy SG, Ghosh S, Agarwala S, Tripathi M.
Synchronous thoracic and abdominal enteric duplication cysts: accurate detection with (99m)Tc-pertechnetate scintigraphy.
Indian Journal of Nuclear Medicine, 30(1), 59–61, 2015.
Citations: 21
Significance: Reported a rare dual enteric duplication case, highlighting the role of nuclear imaging in pediatric diagnostics. -
Gupta B, Das P, Ghosh S, Manhas J, Sen S, Pal S, Sahni P, Upadhyay AD, Panda SK, Gupta SD.
Identification of high-risk aberrant crypt foci and mucin-depleted foci in the human colon with study of colon cancer stem cell markers.
Clinical Colorectal Cancer, 16(3), 204–213, 2017.
Citations: 19
Significance: Characterized early pre-neoplastic lesions and stem cell markers in colorectal cancer, contributing to early detection research. -
Khanna G, Ghosh S, Barwad A, Yadav R, Das P.
Mucosal Schwann cell hamartoma of gall bladder: a novel observation.
Pathology, 50(4), 480–482, 2018.
Citations: 13
Significance: Described an unusual benign Schwann cell lesion of the gallbladder, expanding the pathological spectrum of biliary tract disorders.
Strengths for the Best Innovator Award
1. Pioneering Work in Stem Cell and Cellular Therapies
Dr. Ghosh has demonstrated outstanding innovation in developing and implementing advanced stem cell transplant protocols, including both autologous and allogeneic transplants for hematologic malignancies. His work has introduced refinements in transplant conditioning, GVHD management, and immune recovery, improving safety and success rates in complex clinical settings. His leadership in CAR-T cell therapy further underscores his commitment to bringing next-generation immunotherapies to the Indian healthcare landscape.
2. Translational Research Linking Laboratory and Clinical Medicine
With a strong foundation in pathology and hematology, Dr. Ghosh bridges molecular research and bedside practice. His studies on molecular characterization of hematologic and genetic disorders—including thalassemia, myeloid neoplasms, and pre-neoplastic colon lesions—have led to better diagnostic accuracy and therapeutic planning. His translational mindset ensures that laboratory discoveries are effectively transformed into meaningful clinical outcomes.
3. Leadership in Clinical Trials and Collaborative Research Networks
Dr. Ghosh plays a vital role in national and international clinical trials, serving as Principal Investigator for the HCC CML registry and Co-Investigator in global MDS and AML studies. His contributions to Haematology Care Consortium and ISBMT working groups reflect a deep commitment to collaborative science and large-scale data integration. These initiatives are helping shape policy and practice in hematologic oncology across India.
4. Innovation in Infection Management and Supportive Care
Through his highly cited research on bloodstream infections and antimicrobial resistance in hematology patients, Dr. Ghosh has pioneered infection-control strategies in immunocompromised populations. His work in developing evidence-based antibiotic policies and real-world data on resistant organisms has significantly improved outcomes in transplant and chemotherapy settings, marking a major advancement in supportive care innovation.
5. Academic Excellence and Knowledge Dissemination
Dr. Ghosh’s consistent academic distinction, multiple national awards, and participation in global conferences such as SOHO and APBMT highlight his leadership in knowledge creation and dissemination. His mentorship of trainees and his active role in clinical education foster a culture of inquiry, innovation, and excellence. His research outputs—spanning over twenty peer-reviewed papers—reflect both scientific rigor and the drive to translate evidence into impactful clinical practice.